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Abstract
Mendelian randomization uses genetic variants to make causal inferences about a
modifiable exposure. Subject to a genetic variant satisfying the instrumental vari-
able assumptions, an association between the variant and outcome implies a causal
effect of the exposure on the outcome. Complications arise with a binary exposure
that is a dichotomization of a continuous risk factor (for example, hypertension is
a dichotomization of blood pressure). This can lead to violation of the exclusion re-
striction assumption: the genetic variant can influence the outcome via the continuous
risk factor even if the binary exposure does not change. Provided the instrumental
variable assumptions are satisfied for the underlying continuous risk factor, causal
inferences for the binary exposure are valid for the continuous risk factor. Causal
estimates for the binary exposure assume the causal effect is a stepwise function at
the point of dichotomization. Even then, estimation requires further parametric as-
sumptions. Under monotonicity, the causal estimate represents the average causal
effect in ‘compliers’, individuals for whom the binary exposure would be present if
they have the genetic variant and absent otherwise. Unlike in randomized trials, ge-
netic compliers are unlikely to be a large or representative subgroup of the population.
Under homogeneity, the causal effect of the exposure on the outcome is assumed con-
stant in all individuals; often an unrealistic assumption. We here provide methods for
causal estimation with a binary exposure (although subject to all the above caveats).
Mendelian randomization investigations with a dichotomized binary exposure should
be conceptualized in terms of an underlying continuous variable.
Mendelian randomization is the use of genetic variants as instrumental variables
to test for or estimate the causal effect of a risk factor (referred to here as an ex-
posure) on an outcome using observational data (Davey Smith and Ebrahim, 2003,
Burgess and Thompson, 2015). The primary objective of Mendelian randomization
is to find modifiable exposures that are worthwhile therapeutic targets and can be
intervened on to improve health outcomes. An instrumental variable must be as-
sociated with the exposure of interest (relevance), only affects the outcome through
the exposure (exclusion restriction), and does not share any causes with the outcome
(exchangeability). Recently, several Mendelian randomization studies have employed
binary measures as the exposure variable. Examples include analyses assessing the
causal effect of cannabis initiation on schizophrenia (and of schizophrenia on cannabis
initiation) (Gage et al., 2017, Vaucher et al., 2017), and of diabetes status on endome-
trial cancer (Nead et al., 2015). In this short manuscript, we discuss issues relating
to causal estimation in the Mendelian randomization setting with a binary exposure.
For ease of presentation, we initially assume a single genetic variant is used as an
instrumental variable; this restriction is later relaxed.
The intended primary audience of this manuscript is Mendelian randomization
practitioners, and the aim of the manuscript is to communicate the practical conse-
quences of these methodological issues for Mendelian randomization investigations.
As such, we focus on methods and approaches that are likely to be the most relevant
to scenarios that are common in applied practice. In particular, we focus on methods
that can be performed using summarized data, which comprise genetic associations
with the exposure estimated using regression methods, that are routinely reported by
large consortia (Burgess et al., 2013). Although our focus is on practitioners, we also
provide technical asides and references for methodologically-focused readers.
Random assignment in a trial as a paradigm instrumental vari-
able
Consider a double-blind, placebo-controlled randomized trial with two time-fixed
treatment arms (referred to as treatment and control) and complete follow-up data.
An intention-to-treat effect estimate is typically reported: the causal effect of alloca-
tion to treatment as opposed to control. When there is substantial non-compliance,
investigators may be interested in testing whether the treatment itself has an effect
on the outcome (as opposed to simply allocation to treatment), or in estimating the
causal effect of the treatment itself. Testing for a treatment or ‘per-protocol’ effect can
be achieved through the intention-to-treat analysis: unless random assignment some-
how affects the outcome directly (e.g., because blinding is broken or a placebo effect
is present), an association between treatment allocation and the outcome will only
arise if the treatment has a causal effect on the outcome (Didelez and Sheehan, 2007).
Estimating the average treatment effect in the full study population further requires
additional homogeneity conditions (Herna´n and Robins, 2006, Aronow and Carnegie,
2013, Wang and Tchetgen Tchetgen, 2018); sufficient conditions are linearity of the in-
strumental variable–exposure, instrumental variable–outcome and exposure–outcome
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relationships with no effect heterogeneity. Without additional conditions, only bounds
for the average treatment effect are obtainable (Balke and Pearl, 1997). These bounds
can also be used to assess the validity of a genetic variant as an instrumental vari-
able (Ramsahai and Lauritzen, 2011, Swanson et al., 2018), although this approach
is rarely informative in practice, and alternative ways of assessing instrument valid-
ity (such as understanding the biological role of the genetic variant, and assessing
its associations with known confounders) are more likely to be fruitful in practice
(Burgess et al., 2015). Alternatively, investigators often estimate an effect in a sub-
group of the population under a weaker assumption.
Specifically, we consider the subgroup of the population consisting of ‘compliers’ –
individuals who would receive the treatment if allocated to treatment, and would not
receive treatment if allocated to not receive treatment. The effect in this subgroup can
be estimated under the assumption that there are no defiers – individuals who would
only take treatment if randomly allocated not to do so, and who would not take treat-
ment if allocated to take it (Angrist et al., 1996). This is known as the monotonicity
assumption – allocation to taking the treatment can only increase the value of the
exposure, not decrease it. This effect, which can be estimated using standard instru-
mental variable techniques, is known as the local average treatment effect (LATE) or
the complier average causal effect (CACE) in the literature (Yau and Little, 2001). Of
note, we cannot identify individual compliers as we cannot see individuals’ treatment
levels under both levels of treatment allocation. However, it is possible to identify
the proportion of the study population who are compliers, and to describe relative
characteristics of the compliers compared to non-compliers using measured baseline
covariates (Angrist and Pischke, 2009). In well-designed randomized trials, compli-
ers are likely to be common, and the assumption that there are no defiers is often
considered reasonable.
Who are the genetic ‘compliers’?
Monotonicity in the context of Mendelian randomization means that increasing the
number of variant alleles for an individual can only increase the exposure from absent
to present (or leave it constant), and can never decrease it. The analogue of ‘compliers’
in Mendelian randomization are individuals who would have the exposure present if
they possess an exposure-increasing genetic variant, but not otherwise. As genetic
variants tend to have small effects on phenotypic variables, such compliers are likely
to be uncommon.
This means that the group of genetic compliers is not likely to be representative of
the general population. Also, the group of compliers may well differ greatly between
different study populations. As an example, folate deficiency has been hypothesized
as a causal risk factor for coronary heart disease (Lewis et al., 2005). The complier
population (and therefore the instrumental variable estimate) would differ greatly in
a population where large numbers of people are borderline folate deficient compared
with a population where relatively few people are folate deficient. (A similar problem
would occur in randomized trials conducted in different populations.) The analogous
assumption in Mendelian randomization to the ‘no defiers’ assumption is that increases
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in the genotype variable would lead to increases (or no change) in the exposure for all
individuals in the population (or equivalently, decreases or no change in the exposure
for all individuals) (Herna´n and Robins, 2006). With a genetic variant that takes
multiple values, the equivalent assumption is that the exposure is a non-decreasing
(or non-increasing) function of the genetic variant. In this case (and in the case with
multiple genetic variants), the instrumental variable estimate is a weighted average of
LATEs (Angrist et al., 2000).
In the context of RCTs, even if individual compliers cannot be identified, the
subgroup of compliers may be of interest either because it represents a large or rep-
resentative subgroup of the population, or due to patterns of non-compliance in the
trial being anticipated to be repeated outside the trial setting. However, in Mendelian
randomization, the subgroup of genetic ‘compliers’ is unlikely to represent those in-
dividuals in the population who would respond to a treatment that influences the
target exposure, particularly if the treatment has a greater effect on the risk factor
than the genetic variant. Hence, under the ‘no defiers’ assumption, the interpreta-
tion of a causal estimate in a Mendelian randomization investigation in which the
instrumental variable assumptions are satisfied is that of an average causal effect in
those individuals whose exposure status would vary depending on whether they have
a particular genetic variant or not. We additionally note that the subgroup of genetic
compliers would differ between genetic variants. This provides yet another reason why
causal estimates based on different genetic variants may vary even if all the genetic
variants are valid instruments.
What is the true risk factor underlying the exposure?
The above interpretation assumes that the instrumental variable assumptions are sat-
isfied. These assumptions imply that the only influence of the instrumental variable
on the outcome is via the exposure – if the instrumental variable changes, but the
exposure stays the same, then the outcome should not change. However, for most
binary exposures used in Mendelian randomization investigations, there is an un-
derlying continuous risk factor for which the binary variable is a dichotomization.
As a simple example, the binary exposure hypertension is a dichotomization of the
continuous risk factor blood pressure. In more complex examples, an underlying con-
tinuous latent variable can be hypothesized even if it cannot be measured, such as a
continuous spectrum of sub-clinical mental health problems for the binary exposure
schizophrenia.
If the binary exposure is a dichotomization of a continuous risk factor, then the
instrumental variable assumptions are likely to be violated. For the example of hy-
pertension, if elevated blood pressure is a causal risk factor for a particular outcome
then genetic variants that are associated with blood pressure will be associated with
the outcome even in a population where no-one suffers from clinically-defined hyper-
tension. Hence, changes in the genetic variants will lead to increases in blood pressure
and consequently to changes in the outcome even if the exposure status for hyperten-
sion remains fixed for all individuals in the population. An instrumental variable for
a continuous exposure can only be an instrumental variable for the dichotomization of
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the exposure if the exposure–outcome causal relationship is a strict stepwise threshold
at the point of dichotomization (in which case the dichotomized exposure is a repre-
sentation of the true risk factor). However, provided that the instrumental variable
assumptions are satisfied for the continuous risk factor, testing for an association with
the outcome is still a valid test of the causal null hypothesis for the binary exposure.
There are two main consequences of this. First, such a Mendelian randomization
study should be conceptualized as an investigation into the (possibly latent) underly-
ing continuous risk factor, rather than the binary dichotomization of this variable. At
minimum, the instrumental variable assumptions should be assessed with the contin-
uous risk factor in mind. Second, a causal estimate from a Mendelian randomization
investigation with a dichotomized binary exposure does not have a clear interpreta-
tion due to the binary exposure variable not capturing the true causal relationship.
There are several reasons why a Mendelian randomization estimate may differ from
the effect of an intervention even for a continuous exposure (for example, genetic
variants have long-term influences acting from the beginning of life, whereas inter-
ventions are more short-term and are applied to mature individuals) (Burgess et al.,
2012, Swanson et al., 2017). With a binary exposure, these concerns are even greater.
Causal estimation with a binary exposure
Despite this, suppose that we want to calculate a causal effect with a binary exposure,
under the assumption that the exposure has a stepwise effect on the outcome. This
may be because we truly believe in the homogeneity assumptions, or we truly believe
in the monotonicity assumption and regard the genetic compliers as a worthwhile
subgroup of the population in which to estimate an average causal effect. Or, more
likely, because a causal effect estimate is required for pragmatic reasons, such as to
perform a power calculation or to inform policymakers of the expected impact of in-
tervention on the exposure. Other reasons for estimating a causal parameter include
efficient testing of the causal null hypothesis with multiple instrumental variables
(under the homogeneity assumptions, the two-stage least squares estimate, or equiva-
lently the inverse-variance weighted estimate, is the optimally efficient combination of
the instruments for testing for a causal effect (Wooldridge, 2009)) and use of a robust
method with multiple genetic variants (such as the MR-Egger method (Bowden et al.,
2015) or weighted median method (Bowden et al., 2016) – these methods make weaker
assumptions, not requiring all genetic variants to satisfy the instrumental variable as-
sumptions). If the binary exposure is a dichotomization of a continuous risk factor,
then power calculations are likely to be conservative, as the effect of the genetic variant
on the outcome will not be fully captured by the binary exposure.
Two options for causal estimation are: i) estimating the effect on the outcome
per (say) 1% absolute increase in the probability of the exposure; ii) estimating the
effect on the outcome per (say) doubling of the probability (or odds) of the exposure.
We concentrate on estimation methods based on regression (usually linear or logistic)
for several reasons. First, often researchers perform their analyses using summarized
association estimates – beta-coefficients from regression analyses of the exposure and
outcome on a genetic variant – and do not have access to individual-level data. These
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beta-coefficients represent the average change in the trait (exposure or outcome) per
additional copy of the effect allele. Secondly, these approaches result in causal es-
timates with a simple and relevant interpretation, and which can be compared to
estimates in the literature from other analytical approaches. Thirdly, often there
are technical restrictions on the data analysis – for example, it may be necessary
to fit a mixed model to account for relatedness between individuals, to adjust for
several principal components of ancestry, or to provide a coordinated approach to
analysis across different datasets. These restrictions are easiest to accommodate in a
regression framework. These estimation procedures require strict linearity and homo-
geneity assumptions; full details are available elsewhere (Herna´n and Robins, 2006,
Didelez and Sheehan, 2007). The parametric assumptions for these two options are
mutually incompatible. Additionally, regression coefficients will generally be varia-
tion dependent on the baseline risk, a nuisance parameter (Richardson et al., 2017).
If individual-level data are available, then alternative approaches to estimation can
be taken (Aronow and Carnegie, 2013, Wang and Tchetgen Tchetgen, 2018).
If the genetic associations with the exposure are estimated using linear regression,
then they represent absolute changes in the prevalence of the exposure. This enables
estimation of the causal effect of an intervention in the prevalence of the exposure
on an absolute scale. It is sensible to scale the causal effect to consider a modest
increase in the prevalence of the exposure (say a 1% or a 10% increase), as a unit
increase would represent the average causal effect of a population intervention from
0% prevalence of the exposure to 100% prevalence – an unrealistic intervention in
practice. However, absolute associations with a binary variable do not make sense in
case-control settings (where cases are those with the exposure), as they depend on
the ratio of cases to controls chosen by the investigator.
If the genetic associations with the exposure are estimated using logistic regres-
sion, then they represent log odds ratios. The causal estimate would then represent
the change in the outcome per unit change in the exposure on the log odds scale. A
unit increase in the log odds of a variable corresponds to a 2.72 (= exp 1)-fold mul-
tiplicative increase in the odds of the variable. If the exposure is rare then the odds
of the exposure is approximately equal to the probability of the exposure. The causal
estimate represents the average change in the outcome per 2.72-fold increase in the
prevalence of the exposure (for example, an increase in the exposure prevalence from
1% to 2.72%). It may be more interpretable to think instead about the average change
in the outcome per doubling (2-fold increase) in the prevalence of the exposure. This
can be obtained by multiplying the causal estimate by 0.693 (= log
e
2).
Discussion
In this short manuscript, we have discussed statistical issues for Mendelian random-
ization with a binary exposure. A summary of the arguments made in the paper
is provided as Figure 1. Under the more plausible assumption of monotonicity, the
estimate from a Mendelian randomization study with a binary exposure represents
the average causal effect in ‘compliers’; the subgroup of individuals for whom the
presence or absence of the genetic variant used as an instrument determines whether
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individuals have the exposure present or not. Under the less plausible assumption of
homogeneity, the estimate of the causal effect only makes sense if the effect of the
exposure on the outcome has a strict stepwise form – only changes in whether the
binary exposure is present or absent will affect the outcome. If the binary exposure is
a dichotomization of a continuous variable, then the causal estimate does not have a
clear interpretation. In such a case, causal inferences will only be valid provided that
the instrumental variable assumptions are satisfied for the continuous risk factor – in
particular, if the effect of the genetic variant on the outcome is completely mediated
via the continuous risk factor. However, as the effect of the genetic variant on the
outcome is not completely mediated via the binary exposure, power calculations are
likely to be conservative.
In summary, applying Mendelian randomization with a binary exposure requires
careful consideration. When the binary exposure is a dichotomization of an underlying
continuous risk factor, causal assumptions should be assessed and causal inferences
should be conceptualized with respect to the underlying continuous risk factor. Tests
for causal effects may be achieved readily without using the exposure information,
but estimation procedures for a binary exposure require strong assumptions that are
unlikely to be biologically plausible in common Mendelian randomization settings.
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Is the binary risk factor
a dichotomization of an underlying
continuous risk factor?
Yes
Better not to estimate a causal effect 
parameter and instead simply to report 
whether the variant(s) are associated 
with the outcome
Is the homogeneity
assumption plausible?
Is the monotonicity
assumption plausible?
Is the subgroup of genetic
compliers an interesting subgroup
to estimate an average causal
effect for?
No, the homogeneity assumption 
is never plausible 
No
No
Yes
No
Yes
The instrumental variable estimate represents the 
average causal effect of the exposure in genetic 
compliers for that variant
“But there are pragmatic reasons why I 
want to estimate a causal effect”
Very well, but in addition to the usual caveats about 
an estimate from Mendelian randomization:
1. Under the monotonicity assumption, the 
instrumental variable estimate is an average 
causal effect for the genetic compliers, a small
and potentially unrepresentative subgroup of 
the population.
2. If the binary risk factor is a dichotomization of 
a continuous risk factor, then the instrumental 
variable estimate no longer has a clear 
interpretation even under the implausible 
homogeneity assumption, and power 
calculations are likely to be underestimated.
No, but I want to make the homogeneity
assumption anyway
The instrumental variable estimate represents the 
causal effect of the exposure (assumed to be a 
stepwise effect that is constant in all individuals)
Figure 1: Flow diagram illustrating the steps needed to consider when considering
whether to estimate a parameter in a Mendelian randomization investigation or not
with a binary risk factor.
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